Aymen I. Idris

Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors

Aymen I. Idris, Rob vanʼt Hof, Iain R. Greig et al. · Nature Medicine · 2005 · 351 citations · Full text

Medicine, Endocrinology, Bone Metabolism +16

Aminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro

Aymen I. Idris, Javier Rojas, Iain R. Greig et al. · Calcified Tissue International · 2008 · 208 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Cannabinoid Receptor Type 1 Protects against Age- Related Osteoporosis by Regulating Osteoblast and Adipocyte Differentiation in Marrow Stromal Cells

Aymen I. Idris, Antonia Sophocleous, Euphemie Landao‐Bassonga et al. · Cell Metabolism · 2009 · 175 citations · Full text

Medicine, Geriatric Medicine, Molecular Medicine +17

Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor

Aymen I. Idris, Antonia Sophocleous, Euphemie Landao‐Bassonga et al. · Endocrinology · 2008 · 144 citations

Medicine, Endocrinology, Pharmacology +17

The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo

Aymen I. Idris, Euphemie Landao‐Bassonga, Stuart H. Ralston · Bone · 2010 · 119 citations

Medicine, Endocrinology, Bone Metabolism +14